GCN2 and perk kinase inhibitors and methods of use thereof | Patent Number 11912668

US 11912668 B2

Application Number17528478

Publication NumberUS 20220274934 A1

Pendency2 years, 3 months, 12 days

Filled DateNov 17, 2021

Priority Date-

Publication DateSep 1, 2022

Expiration DateNov 16, 2041

Inventor/ApplicantsJeffery Zwicker
Kristen Stoltz
Daniel L. Flynn
Salim Javed
Patrick Kearney
Gada Al-Ani
Bertrand Le Bourdonnec
Gada AI-Ani
Bertrand LeBourdonnec
Yu Mi Ahn

ExaminesMCDOWELL, BRIAN E

Art Unit1624

Technology Center1600

Assignments

Deciphera Pharmaceuticals Llc

Current

Deciphera Pharmaceuticals Llc

Original

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

View Concierge Program

See the invalidated claims, subscribe to our Concierge Program.

View Concierge Program

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.